Unknown

Dataset Information

0

CAR-NK cells: A promising cellular immunotherapy for cancer.


ABSTRACT: Natural Killer (NK) cells and CD8+ cytotoxic T cells are two types of immune cells that can kill target cells through similar cytotoxic mechanisms. With the remarkable success of chimeric antigen receptor (CAR)-engineered T (CAR-T) cells for treating haematological malignancies, there is a rapid growing interest in developing CAR-engineered NK (CAR-NK) cells for cancer therapy. Compared to CAR-T cells, CAR-NK cells could offer some significant advantages, including: (1) better safety, such as a lack or minimal cytokine release syndrome and neurotoxicity in autologous setting and graft-versus-host disease in allogenic setting, (2) multiple mechanisms for activating cytotoxic activity, and (3) high feasibility for 'off-the-shelf' manufacturing. CAR-NK cells could be engineered to target diverse antigens, enhance proliferation and persistence in vivo, increase infiltration into solid tumours, overcome resistant tumour microenvironment, and ultimately achieve an effective anti-tumour response. In this review, we focus on recent progress in genetic engineering and clinical application of CAR-NK cells, and discuss current challenges and future promise of CAR-NK cells as a novel cellular immunotherapy in cancer.

SUBMITTER: Xie G 

PROVIDER: S-EPMC7452675 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

CAR-NK cells: A promising cellular immunotherapy for cancer.

Xie Guozhu G   Dong Han H   Liang Yong Y   Ham James Dongjoo JD   Rizwan Romee R   Chen Jianzhu J  

EBioMedicine 20200824


Natural Killer (NK) cells and CD8<sup>+</sup> cytotoxic T cells are two types of immune cells that can kill target cells through similar cytotoxic mechanisms. With the remarkable success of chimeric antigen receptor (CAR)-engineered T (CAR-T) cells for treating haematological malignancies, there is a rapid growing interest in developing CAR-engineered NK (CAR-NK) cells for cancer therapy. Compared to CAR-T cells, CAR-NK cells could offer some significant advantages, including: (1) better safety,  ...[more]

Similar Datasets

| S-EPMC8409419 | biostudies-literature
| S-EPMC9327111 | biostudies-literature
| S-EPMC8080297 | biostudies-literature
| S-EPMC8969382 | biostudies-literature
| S-EPMC9367380 | biostudies-literature
| S-EPMC8377427 | biostudies-literature
| S-EPMC8252313 | biostudies-literature
| S-EPMC10695781 | biostudies-literature
| S-EPMC9024487 | biostudies-literature
| S-EPMC4515552 | biostudies-literature